{"id":2006,"date":"2025-09-09T19:24:12","date_gmt":"2025-09-09T17:24:12","guid":{"rendered":"https:\/\/roneuro.ro\/blog\/?p=2006"},"modified":"2025-11-25T15:54:41","modified_gmt":"2025-11-25T13:54:41","slug":"terapia-cu-celule-stem-in-neurologie","status":"publish","type":"post","link":"https:\/\/roneuro.ro\/blog\/terapia-cu-celule-stem-in-neurologie\/","title":{"rendered":"Terapia cu celule stem \u00een neurologie"},"content":{"rendered":"\n<h2>Terapia cu celule stem \u00een neurologie<\/h2>\n<p>Terapia cu celule stem \u00een neurologie a\u00a0deschis noi direc\u021bii pentru \u00een\u021belegerea, tratarea \u0219i poten\u021biala vindecare a unei game largi de tulbur\u0103ri neurologice [17].<\/p>\n<p>Bolile neurologice precum <a href=\"https:\/\/roneuro.ro\/blog\/ce-este-boala-parkinson\/\">Parkinson<\/a>, <a href=\"https:\/\/roneuro.ro\/blog\/dementa-alzheimer\/\">Alzheimer<\/a>, <a href=\"https:\/\/roneuro.ro\/blog\/ce-este-scleroza-multipla\/\">scleroza multipl\u0103<\/a>, scleroza lateral\u0103 amiotrofic\u0103 \u0219i leziunile m\u0103duvei spin\u0103rii se refer\u0103 la degenerarea progresiv\u0103 \u0219i moartea celulelor neuronale \u0219i de sustinere [18].<\/p>\n<p>Deoarece sistemul nervos central are o capacitate regenerativ\u0103 limitat\u0103, terapiile bazate pe celule stem ofer\u0103 speran\u021b\u0103 acolo unde tratamentele conven\u021bionale sunt insuficiente [19].<\/p>\n<p>Prin diferen\u021bierea celulelor stem \u00een neuroni sau celule gliale \u0219i transplantarea lor \u00een zone deteriorate ale creierului [20] sau m\u0103duvei spin\u0103rii, cercet\u0103torii \u00ee\u0219i propun s\u0103 restabileasc\u0103 func\u021bia, s\u0103 amelioreze simptomele sau chiar s\u0103 opreasc\u0103 progresia bolii [21].<\/p>\n<p>Celulele stem sunt utilizate \u00een modele de laborator pentru a studia fiziopatologia bolilor neurologice \u00een vederea fabric\u0103rii de noi medicamente [22].<\/p>\n<h2>Care sunt beneficiile terapiilor cu celule stem?<\/h2>\n<p>Beneficiile terapiilor cu celule stem \u00een neurologie sunt promi\u021b\u0103toare. Pacien\u021bii care sufer\u0103 de afec\u021biuni incurabile pot experimenta func\u021bii motorii \u00eembun\u0103t\u0103\u021bite, simptome reduse \u0219i o mai bun\u0103 calitate a vie\u021bii [29].<\/p>\n<p>Transplanturile de celule stem la pacien\u021bii cu <a href=\"https:\/\/roneuro.ro\/blog\/tratament-pentru-boala-parkinson\/\">boala Parkinson<\/a> au demonstrat un poten\u021bial de refacere a neuronilor produc\u0103tori de dopamin\u0103, care se pierd progresiv \u00een boal\u0103 [30].<\/p>\n<p>\u00cen cazul leziunilor m\u0103duvei spin\u0103rii, celulele stem pot stimula regenerarea neuronal\u0103, ajut\u00e2nd la restabilirea func\u021biilor senzoriale \u0219i motorii [31].<\/p>\n<p>Utilizarea celulelor stem \u00een studierea mecanismelor patologice \u00een condi\u021bii de laborator \u0219i evaluarea medicamentelor, accelereaz\u0103 dezvoltarea unor tratamente direc\u021bionate \u0219i eficiente [32].<\/p>\n<p><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter wp-image-2009\" src=\"https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/beneficii-terapie-celule-STEM-scaled.jpg\" alt=\"\" width=\"650\" height=\"237\" title=\"\" srcset=\"https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/beneficii-terapie-celule-STEM-scaled.jpg 2560w, https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/beneficii-terapie-celule-STEM-300x109.jpg 300w, https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/beneficii-terapie-celule-STEM-1024x373.jpg 1024w, https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/beneficii-terapie-celule-STEM-768x280.jpg 768w, https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/beneficii-terapie-celule-STEM-1536x560.jpg 1536w, https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/beneficii-terapie-celule-STEM-2048x746.jpg 2048w, https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/beneficii-terapie-celule-STEM-750x273.jpg 750w, https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/beneficii-terapie-celule-STEM-1140x415.jpg 1140w\" sizes=\"(max-width: 650px) 100vw, 650px\" \/><\/p>\n<h2>Care sunt tipurile de celule stem utilizate \u00een cercetare \u0219i terapie?<\/h2>\n<p>Printre diferitele tipuri de celule stem, cele mai frecvent utilizate \u00een cercetare \u0219i terapie sunt: celulele stem embrionare, celulele stem adulte \u0219i celulele stem reprogramate genetic [23].<\/p>\n<p><strong>Celulele stem embrionare<\/strong> sunt derivate din embrioni \u00een stadiu incipient \u0219i pot deveni orice tip de celul\u0103 din organism.<\/p>\n<p><strong>Celulele stem adulte<\/strong>, se g\u0103sesc \u00een \u021besuturi precum m\u0103duva osoas\u0103 \u0219i creierul, sunt capabile s\u0103 formeze o gam\u0103 limitat\u0103 de tipuri de celule.<\/p>\n<p><strong>Celulele stem pluripotente induse<\/strong> sunt celule stem adulte care au fost reprogramate genetic cu scopul de a oferi pluripoten\u021ba celulelor stem embrionare f\u0103r\u0103 \u00eengrijor\u0103rile etice asociate.<\/p>\n<h2>Ce este terapia cu celule stem?<\/h2>\n<p>Terapia cu celule stem, cunoscut\u0103 \u0219i sub denumirea de medicin\u0103 regenerativ\u0103, este un tratament modern care utilizeaz\u0103 celule stem pentru a repara sau \u00eenlocui celulele \u0219i \u021besuturile deteriorate sau bolnave din organism. Aceasta implic\u0103 introducerea \u00een corpul unui pacient a celulelor stem, care au poten\u021bialul de a se diferen\u021bia \u00een diverse tipuri de celule, pentru a promova vindecarea \u0219i a restabili func\u021bia.<\/p>\n<p>Celulele stem sunt celule nediferen\u021biate (deoarece nu au o func\u021bie specific\u0103), care servesc drept elemente constitutive fundamentale ale corpului uman [1]. Ele au capacitatea de a se re\u00eenoi (prin diviziune celular\u0103) \u0219i\/sau de a se transforma (diferen\u021biere) \u00een alte tipuri diferite de celule specializate (diferen\u021biate) precum celule musculare, epiteliale, nervoase, osoase, etc, put\u00e2nd regenera \u021besuturile afectate [2].<\/p>\n<p>Transformarea se produce cu ajutorul unor molecule specializate [3] (numite factori de cre\u0219tere \u0219i regenerare) \u0219i a fenomenului de plasticitate local\u0103 [4] (copierea caracteristicilor celulelor \u00eenvecin\u0103tate).<\/p>\n<p>Aceste caracteristici fac din celulele stem un instrument util \u00een biologia dezvolt\u0103rii [5] (biologia regener\u0103rii, metamorfozei \u0219i a cre\u0219terii \u0219i diferen\u021bierii celulelor stem \u00een organismul adult) [6].<\/p>\n<h2>De c\u00e2te feluri sunt celulele stem?<\/h2>\n<p>Exist\u0103 mai multe tipuri de celule stem, clasificate dup\u0103 capacitatea lor de a se transforma. Cele mai versatile sunt cele din embrioni, care pot deveni orice celul\u0103 din corp, \u00een timp ce celulele stem adulte au capacit\u0103\u021bi mai limitate (de exemplu, mezenchimale \u0219i hematopoietice).<\/p>\n<p>Ovulul recent fertilizat formeaz\u0103 cea mai puternic\u0103 celul\u0103 stem din c\u00e2te exist\u0103 \u0219i se nume\u0219te celul\u0103 stem totipotent\u0103 [7]. Acest tip de celule se diferen\u021biaz\u0103 \u00een celule care vor alc\u0103tui \u021besuturile embrionare \u0219i extraembrionare (de exemplu, placenta) [8,9].<\/p>\n<p>\u00cen stadiul dezvolt\u0103rii embrionare, ele vor crea diverse structuri \u0219i se numesc celule stem embrionare [10].<\/p>\n<p>La v\u00e2rsta adult\u0103, celulele stem contribuie la formarea, repararea \u0219i regenerarea tuturor \u021besuturilor unei fiin\u021be umane adulte, se numesc celule stem adulte [11] \u0219i se \u00eempart \u00een alte dou\u0103 categorii [12]: <strong>celule stem mezenchimale<\/strong> \u0219i <strong>celule stem hematopoietice<\/strong> [13].<\/p>\n<p><strong>Celulele stem mezenchimale<\/strong> [14] se g\u0103sesc \u00een <em>\u021besutul<\/em> cordonului ombilical \u0219i m\u0103duva osoas\u0103 av\u00e2nd capacitatea de a se transforma \u00een: celule osoase, cartilaginoase, musculare \u0219i celule grase.<\/p>\n<p><strong>Celulele stem hematopoietice<\/strong> [15] se g\u0103sesc \u00een <em>s\u00e2ngele<\/em> din cordonul ombilical \u0219i m\u0103duva osoas\u0103) av\u00e2nd capacitatea de a se transforma \u00een celule sanguine (globule ro\u0219ii, albe, etc) [16].<\/p>\n<ul>\n<li>Ovulul recent fertilizat;<\/li>\n<li>Celule stem embrionare;<\/li>\n<li>Celule stem adulte:\n<ul>\n<li>Celule stem mezenchimale;<\/li>\n<li>Celule stem hematopoietice.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><img decoding=\"async\" class=\"aligncenter wp-image-2007\" src=\"https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/tipuri-de-celule-STEM-scaled.jpg\" alt=\"\" width=\"650\" height=\"534\" title=\"\" srcset=\"https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/tipuri-de-celule-STEM-scaled.jpg 2560w, https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/tipuri-de-celule-STEM-300x246.jpg 300w, https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/tipuri-de-celule-STEM-1024x841.jpg 1024w, https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/tipuri-de-celule-STEM-768x631.jpg 768w, https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/tipuri-de-celule-STEM-1536x1261.jpg 1536w, https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/tipuri-de-celule-STEM-2048x1682.jpg 2048w, https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/tipuri-de-celule-STEM-750x616.jpg 750w, https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/tipuri-de-celule-STEM-1140x936.jpg 1140w\" sizes=\"(max-width: 650px) 100vw, 650px\" \/><\/p>\n<h2>Cum se poate preg\u0103ti pacientul pentru recoltarea celulelor stem?<\/h2>\n<p>Preg\u0103tirea pentru recoltarea celulelor stem (cunoscut\u0103 \u0219i sub denumirea de colectare a celulelor stem sau aferez\u0103 a celulelor stem) depinde de tipul de celule stem colectate (de obicei, celule stem hematopoietice din m\u0103duva osoas\u0103 sau s\u00e2ngele periferic) [24].<\/p>\n<p>Evaluarea medical\u0103 const\u0103 \u00een: analiza istoricului medical al pacientului, examen fizic, analize sanguine, precum \u0219i evaluarea riscurilor anesteziei generale, mai ales \u00een cazul recolt\u0103rii m\u0103duvei osoase [25].<\/p>\n<p>Preg\u0103tirea preliminar\u0103 necesit\u0103 injec\u021bii pentru stimularea produc\u021biei de celule stem din s\u00e2nge, care se face cu 4-5 zile \u00eenaintea procedurii de recoltare a celulelor stem din s\u00e2nge. Pacientul trebuie s\u0103 evite consumul de alcool, fumatul \u0219i medicamentele anticoagulante [26].<\/p>\n<p>Analizele sanguine trebuie s\u0103 evalueze func\u021bia renal\u0103 \u0219i hepatic\u0103, num\u0103rul de leucocite \/ trombocite, testul pentru compatibilitate donoare, teste pentru boli infec\u021bioase, anemie precum \u0219i test de sarcin\u0103 (\u00een cazul femeilor) [27,28].<\/p>\n<h2>Resurse \u0219i suport pentru pacien\u021bi<\/h2>\n<p>Dac\u0103 ave\u021bi deja un diagnostic de boal\u0103 neurodegenerativ\u0103 sever\u0103 sau leziuni ale m\u0103duvei spin\u0103rii \u0219i dori\u021bi o evaluare suplimentar\u0103 pentru \u00een\u021belegerea stadiului actual al afec\u021biunii, precum \u0219i o discu\u021bie detaliat\u0103 privind op\u021biunile terapeutice, v\u0103 invit\u0103m s\u0103 v\u0103 programa\u021bi la o consulta\u021bie la Institutul RoNeuro<span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">contact\u00e2nd recep\u021bia <strong>Institutului RoNeuro<\/strong> la num\u0103rul de telefon<\/span><b> <a href=\"tel:+40374462222\">0374 46 2222<\/a><\/b><span style=\"font-weight: 400;\">, <strong>luni \u0219i mar\u021bi \u00eentre orele 08:00 &#8211; 19:00<\/strong>, iar de <strong>miercuri p\u00e2n\u0103 vineri \u00eentre orele 08:00 &#8211; 18:00<\/strong>.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">La momentul program\u0103rii, pute\u021bi opta \u0219i pentru consulta\u021bie neurologic\u0103 gratuit\u0103, decontat\u0103 prin Casa Na\u021bional\u0103 de Asigur\u0103ri de S\u0103n\u0103tate.\u00a0<\/span><\/p>\n<p style=\"text-align: center;\"><a style=\"background-color: #6852ed; color: white; text-decoration: none; border: none; padding: 10px 20px; cursor: pointer; display: inline-block;\" href=\"https:\/\/www.roneuro.ro\/progamari.html\">Program\u0103ri online neurologie<\/a><\/p>\n<p><span style=\"font-weight: 400;\">Locui\u021bi \u00eentr-o zon\u0103 izolat\u0103 sau nu v\u0103 pute\u021bi deplasa la clinic\u0103? Institutul RoNeuro ofer\u0103 \u0219i op\u021biunea de <\/span><a href=\"https:\/\/www.roneuro.ro\/telemedicina.html\" target=\"_blank\" rel=\"noopener\">telemedicin\u0103<\/a>.<\/p>\n<h2>Care sunt riscurile utiliz\u0103rii celulelor stem?<\/h2>\n<p>Terapiile cu celule stem nu sunt lipsite de riscuri \u0219i limit\u0103ri. O preocupare major\u0103 este posibilitatea respingerii transplantului [33], adic\u0103 sistemul imunitar al pacientului atac\u0103 celulele transplantate sau boala gref\u0103 contra gazd\u0103 [34], adic\u0103 celulele stem transplantate atac\u0103 \u021besuturile organismului gazd\u0103.<\/p>\n<p>Apari\u021bia unor tumori este un alt risc semnificativ, mai ales \u00een cazul utiliz\u0103rii celulelor stem embrionare care, dac\u0103 nu sunt controlate corespunz\u0103tor, se pot \u00eenmul\u021bi necontrolat. Utilizarea celulelor stem adulte sunt mai sigure dar pot avea alte efecte secundare [35].<\/p>\n<p>Efectele secundare pe termen lung ale transplantului de celule stem nu sunt \u00eenc\u0103 pe deplin \u00een\u021belese, iar variabilitatea r\u0103spunsurilor pacien\u021bilor r\u0103m\u00e2ne o provocare [36].<\/p>\n<p>Efectele secundare pot include: oboseal\u0103, pierderea apetitului, probleme de respira\u021bie, grea\u021b\u0103, infec\u021bii, s\u00e2nger\u0103ri, dureri musculare sau de articula\u021bii, probleme cardiace \u0219i de fertilitate [37].<\/p>\n<p>Pot s\u0103 apar\u0103 probleme legate de metodele de administrare, dozajul \u0219i integrarea celulelor stem transplantate \u00een \u021besutul existent [38].<\/p>\n<ul>\n<li>Respingerea transplantului;<\/li>\n<li>Boala gref\u0103 contra gazd\u0103;<\/li>\n<li>Apari\u021bia tumorilor;<\/li>\n<li>Efecte secundare;<\/li>\n<li>Probleme de administrare \u0219i dozaj.<\/li>\n<\/ul>\n<p><img decoding=\"async\" class=\"aligncenter wp-image-2008\" src=\"https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/riscurile-terapiei-cu-celule-STEM-scaled.jpg\" alt=\"\" width=\"650\" height=\"314\" title=\"\" srcset=\"https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/riscurile-terapiei-cu-celule-STEM-scaled.jpg 2560w, https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/riscurile-terapiei-cu-celule-STEM-300x145.jpg 300w, https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/riscurile-terapiei-cu-celule-STEM-1024x494.jpg 1024w, https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/riscurile-terapiei-cu-celule-STEM-768x371.jpg 768w, https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/riscurile-terapiei-cu-celule-STEM-1536x741.jpg 1536w, https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/riscurile-terapiei-cu-celule-STEM-2048x988.jpg 2048w, https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/riscurile-terapiei-cu-celule-STEM-750x362.jpg 750w, https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/riscurile-terapiei-cu-celule-STEM-1140x550.jpg 1140w\" sizes=\"(max-width: 650px) 100vw, 650px\" \/><\/p>\n<h2>Care sunt problemele etice \u0219i juridice legate de utilizarea celulelor stem?<\/h2>\n<p>Considera\u021biile etice reprezint\u0103 un aspect central al dezbaterii privind celulele stem [39]. Utilizarea celulelor stem embrionare implic\u0103 distrugerea embrionilor umani, ridic\u00e2nd \u00eentreb\u0103ri morale despre \u00eenceputul vie\u021bii umane [40].<\/p>\n<p>De\u0219i celulele stem pluripotente induse au atenuat o parte din aceste \u00eengrijor\u0103ri, exist\u0103 probleme legate de consim\u021b\u0103m\u00e2nt, clonare \u0219i modificare genetic\u0103 [41].<\/p>\n<p>La acestea se adaug\u0103 probleme juridice legate de studierea celulelor stem \u00een clinici private nereglementate [42], care ofer\u0103 terapii cu celule stem nedovedite \u0219tiin\u021bific [43], pentru pacien\u021bii vulnerabili care caut\u0103 ultima speran\u021b\u0103.<\/p>\n<h2>Care este stadiul cercet\u0103rilor actuale \u00een domeniul celulelor stem?<\/h2>\n<p>Cercetarea celulelor stem avanseaz\u0103 \u00eentr-un ritm alert. Studiile clinice sunt \u00een desf\u0103\u0219urare la nivel mondial, test\u00e2ndu-se siguran\u021ba \u0219i eficacitatea diferitelor interven\u021bii bazate pe celule stem pentru boli neurologice \u0219i de alt\u0103 natur\u0103 [44] (precum autism [45], boli autoimune [46], afec\u021biuni cardiovasculare [47], etc).<\/p>\n<p>S-au \u00eenregistrat progrese \u00een rafinarea tehnicilor de diferen\u021biere, asigurarea purit\u0103\u021bii celulare \u0219i \u00eembun\u0103t\u0103\u021birea rezultatelor transplantului [48].<\/p>\n<p>De\u0219i pu\u021bine terapii au ob\u021binut aprobarea de reglementare complet\u0103, num\u0103rul tot mai mare de dovezi sus\u021bine poten\u021bialul celulelor stem de a deveni o parte integrant\u0103 a strategiilor de tratament neurologic [49].<\/p>\n<h2>Care sunt perspectivele de viitor ale terapiilor cu celule stem?<\/h2>\n<p>Viitorul terapiei cu celule stem are o promisiune imens\u0103. Progresele \u00een tehnologiile de editare genetic\u0103 (CRISPR-Cas9) pot m\u0103ri siguran\u021ba \u0219i eficacitatea aplica\u021biilor terapeutice [50].<\/p>\n<p>Abord\u0103rile medicale personalizate care utilizeaz\u0103 celulele stem pluripotente induse (reprogramate genetic), derivate de la pacient, ar putea elimina respingerea imun\u0103 permi\u021b\u00e2nd realizarea unor terapii targhetizate [51].<\/p>\n<p>\u00cen plus, combinarea terapiei cu celule stem cu bioingineria, sau imprimarea 3D a \u021besuturilor, ar putea revolu\u021biona repararea \u021besuturilor \u0219i regenerarea organelor [52].<\/p>\n<h2>Concluzii<\/h2>\n<p>Celulele stem reprezint\u0103 o frontier\u0103 \u00een medicina modern\u0103, \u00een special \u00een tratamentul bolilor neurologice. Propriet\u0103\u021bile lor unice le permit s\u0103 regenereze \u021besuturile deteriorate \u0219i s\u0103 ofere speran\u021b\u0103 pentru afec\u021biuni, considerate p\u00e2n\u0103 acum incurabile.<\/p>\n<p>De\u0219i exist\u0103 numeroase preocup\u0103ri etice \u0219i de siguran\u021b\u0103 clinic\u0103, cercetarea continu\u0103 \u0219i progresele tehnologice creeaz\u0103 o imagine promi\u021b\u0103toare. Terapiile cu celule stem nu sunt doar o posibilitate teoretic\u0103, ci o realitate emergent\u0103 care are poten\u021bialul de a transforma viitorul asisten\u021bei medicale.<\/p>\n<p>Pe m\u0103sur\u0103 ce \u00een\u021belegerea noastr\u0103 despre sistemul nervos se aprofundeaz\u0103 \u0219i tehnologia progreseaz\u0103, terapiile cu celule stem sunt susceptibile de a deveni o piatr\u0103 de temelie a \u00eengrijirii neurologice.<\/p>\n<h2>Referin\u021be<\/h2>\n<ol>\n<li>Mayo Foundation for Medical Education and Research, Stem cells: What they are and what they do. Available at: <a href=\"https:\/\/www.mayoclinic.org\/tests-procedures\/bone-marrow-transplant\/in-depth\/stem-cells\/art-20048117\" target=\"_blank\" rel=\"noopener\">https:\/\/www.mayoclinic.org\/tests-procedures\/bone-marrow-transplant\/in-depth\/stem-cells\/art-20048117<\/a><\/li>\n<li>Tian Z, Yu T, Liu J, Wang T, Higuchi A. Introduction to stem cells. Prog Mol Biol Transl Sci. 2023;199:3-32. doi: 10.1016\/bs.pmbts.2023.02.012. Available at: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37678976\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/37678976\/<\/a><\/li>\n<li>Piku\u0142a M, Langa P, Kosikowska P, Trzonkowski P. Kom\u00f3rki macierzyste i czynniki wzrostuw gojeniu ran [Stem cells and growth factors in wound healing]. Postepy Hig Med Dosw (Online). 2015 Jan 2;69:874-85. Polish. doi: 10.5604\/17322693.1162989. Available at: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26270514\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/26270514\/<\/a><\/li>\n<li>Filip S, Mokry J, Horacek J, English D. Stem cells and the phenomena of plasticity and diversity: a limiting property of carcinogenesis. Stem Cells Dev. 2008 Dec;17(6):1031-8. doi: 10.1089\/scd.2007.0234 Available at: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/19006453\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/19006453\/<\/a><\/li>\n<li>Kim Y, Kim I, Shin K. A new era of stem cell and developmental biology: from blastoids to synthetic embryos and beyond. Exp Mol Med. 2023 Oct;55(10):2127-2137. doi: 10.1038\/s12276-023-01097-8. Available at: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37779144\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/37779144\/<\/a><\/li>\n<li>Gilbert SF. Developmental biology, the stem cell of biological disciplines. PLoS Biol. 2017 Dec 28;15(12):e2003691. doi: 10.1371\/journal.pbio.2003691. Available at: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29284160\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/29284160\/<\/a><\/li>\n<li>Zakrzewski W, Dobrzy\u0144ski M, Szymonowicz M, Rybak Z. Stem cells: past, present, and future. Stem Cell Res Ther. 2019 Feb 26;10(1):68. doi: 10.1186\/s13287-019-1165-5. Available at: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6390367\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6390367\/<\/a><\/li>\n<li>Ishiuchi T, Sakamoto M. Molecular mechanisms underlying totipotency. Life Sci Alliance. 2023 Sep 4;6(11):e202302225. doi: 10.26508\/lsa.202302225. Available at: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10480501\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10480501\/<\/a><\/li>\n<li>Malik V, Wang J. Pursuing totipotency: authentic totipotent stem cells in culture. Trends Genet. 2022 Jul;38(7):632-636. doi: 10.1016\/j.tig.2022.03.012. Available at: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9197991\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9197991\/<\/a><\/li>\n<li>Gordeev MN, Zinovyeva AS, Petrenko EE, Lomert EV, Aksenov ND, Tomilin AN, Bakhmet EI. Embryonic Stem Cell Differentiation to Definitive Endoderm As a Model of Heterogeneity Onset During Germ Layer Specification. Acta Naturae. 2024 Oct-Dec;16(4):62-72. doi: 10.32607\/actanaturae.27510. Available at: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39877013\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/39877013\/<\/a><\/li>\n<li>Mariano ED, Teixeira MJ, Marie SK, Lepski G. Adult stem cells in neural repair: Current options, limitations and perspectives. World J Stem Cells. 2015 Mar 26;7(2):477-82. doi: 10.4252\/wjsc.v7.i2.477. Available at: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4369503\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4369503\/<\/a><\/li>\n<li>Ogawa M, Larue AC, Watson PM, Watson DK. Hematopoietic stem cell origin of mesenchymal cells: opportunity for novel therapeutic approaches. Int J Hematol. 2010 Apr;91(3):353-9. doi: 10.1007\/s12185-010-0554-4. Epub 2010 Mar 26. Available at: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20336396\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/20336396\/<\/a><\/li>\n<li>Battiwalla M, Hematti P. Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy. 2009;11(5):503-15. doi: 10.1080\/14653240903193806. Available at: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC2766085\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC2766085\/<\/a><\/li>\n<li>Ding DC, Shyu WC, Lin SZ. Mesenchymal stem cells. Cell Transplant. 2011;20(1):5-14. doi: 10.3727\/096368910X. PMID: 21396235. https:\/\/pubmed.ncbi.nlm.nih.gov\/21396235\/<\/li>\n<li>Hawley RG, Ramezani A, Hawley TS. Hematopoietic stem cells. Methods Enzymol. 2006;419:149-79. doi: 10.1016\/S0076-6879(06)19007-2. Available at: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17141055\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/17141055\/<\/a><\/li>\n<li>Singh VK, Saini A, Kalsan M, Kumar N, Chandra R. Describing the Stem Cell Potency: The Various Methods of Functional Assessment and In silico Diagnostics. Front Cell Dev Biol. 2016 Nov 22;4:134. doi: 10.3389\/fcell.2016.00134. Available at: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5118841\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5118841\/<\/a><\/li>\n<li>Ul Hassan A, Hassan G, Rasool Z. Role of stem cells in treatment of neurological disorder. Int J Health Sci (Qassim). 2009 Jul;3(2):227-33. Available at: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3068820\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3068820\/<\/a><\/li>\n<li>Rahimi Darehbagh R, Seyedoshohadaei SA, Ramezani R, Rezaei N. Stem cell therapies for neurological disorders: current progress, challenges, and future perspectives. Eur J Med Res. 2024 Jul 25;29(1):386. doi: 10.1186\/s40001-024-01987-1. Available at: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39054501\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/39054501\/<\/a><\/li>\n<li>Hoang DM, Pham PT, Bach TQ, Ngo ATL, Nguyen QT, Phan TTK, Nguyen GH, Le PTT, Hoang VT, Forsyth NR, Heke M, Nguyen LT. Stem cell-based therapy for human diseases. Signal Transduct Target Ther. 2022 Aug 6;7(1):272. doi: 10.1038\/s41392-022-01134-4. Available at: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9357075\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9357075\/<\/a><\/li>\n<li>Rust R, Tackenberg C. Stem Cell Therapy for Repair of the Injured Brain: Five Principles. Neuroscientist. 2024 Feb;30(1):10-16. doi: 10.1177\/10738584221110100. Available at: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10822053\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10822053\/<\/a><\/li>\n<li>Nandoe Tewarie RS, Hurtado A, Bartels RH, Grotenhuis A, Oudega M. Stem cell-based therapies for spinal cord injury. J Spinal Cord Med. 2009;32(2):105-14. doi: 10.1080\/10790268.2009.11760761. Available at: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC2678281\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC2678281\/<\/a><\/li>\n<li>Steindler DA. Stem cells, regenerative medicine, and animal models of disease. ILAR J. 2007;48(4):323-38. doi: 10.1093\/ilar.48.4.323. Available at: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17712220\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/17712220\/<\/a><\/li>\n<li>Poliwoda S, Noor N, Downs E, Schaaf A, Cantwell A, Ganti L, Kaye AD, Mosel LI, Carroll CB, Viswanath O, Urits I. Stem cells: a comprehensive review of origins and emerging clinical roles in medical practice. Orthop Rev (Pavia). 2022 Aug 25;14(3):37498. doi: 10.52965\/001c.37498. Available at: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9404248\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9404248\/<\/a><\/li>\n<li>Mohammadi S, Malek Mohammadi A, Nikbakht M, Norooznezhad AH, Alimoghaddam K, Ghavamzadeh A. Optimizing Stem Cells Mobilization Strategies to Ameliorate Patient Outcomes: A Review of Guide- lines and Recommendations. Int J Hematol Oncol Stem Cell Res. 2017 Jan 1;11(1):78-88. Available at: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5338286\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5338286\/<\/a><\/li>\n<li>Horowitz MM, Confer DL. Evaluation of hematopoietic stem cell donors. Hematology Am Soc Hematol Educ Program. 2005:469-75. doi: 10.1182\/asheducation-2005.1.469. Available at: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16304422\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/16304422\/<\/a><\/li>\n<li>InformedHealth.org [Internet]. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2006-. In brief: Harvesting blood stem cells for transplantation. [Updated 2023 Jan 31]. Available at: <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279428\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279428\/<\/a><\/li>\n<li>De Moor B, Sprangers B. Testing the functional reserve of the kidney before hematopoietic stem cell transplantation: doubt remains. Clin Kidney J. 2023 Apr 6;16(6):905-908. doi: 10.1093\/ckj\/sfad078. Available at: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10229275\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10229275\/<\/a><\/li>\n<li>Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, Van Lint MT, Wingard JR, Tichelli A; Center for International Blood and Marrow Transplant Research; American Society for Blood and Marrow Transplantation; European Group for Blood and Marrow Transplantation; Asia-Pacific Blood and Marrow Transplantation Group; Bone Marrow Transplant Society of Australia and New Zealand; East Mediterranean Blood and Marrow Transplantation Group; Sociedade Brasileira de Transplante de Medula Ossea. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Bone Marrow Transplant. 2012 Mar;47(3):337-41. doi: 10.1038\/bmt.2012.5. Available at: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3393084\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3393084\/<\/a><\/li>\n<li>Chow SK, Gao Q, Pius A, Morita M, Ergul Y, Murayama M, Shinohara I, Cekuc MS, Ma C, Susuki Y, Goodman SB. The Advantages and Shortcomings of Stem Cell Therapy for Enhanced Bone Healing. Tissue Eng Part C Methods. 2024 Oct;30(10):415-430. doi: 10.1089\/ten.TEC.2024.0252. Available at: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39311464\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/39311464\/<\/a><\/li>\n<li>Zeng X, Qin H. Stem Cell Transplantation for Parkinson&#8217;s Disease: Current Challenges and Perspectives. Aging Dis. 2022 Dec 1;13(6):1652-1663. doi: 10.14336\/AD.2022.0312. Available at: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9662280\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9662280\/<\/a><\/li>\n<li>Wang X, Hu X, Xie Y, Zhao T, Liu L, Liu C. Spinal cord neural stem cells derived from human embryonic stem cells promote synapse regeneration and remyelination in spinal cord injury model rats. Eur J Neurosci. 2024 Dec;60(11):6920-6934. doi: 10.1111\/ejn.16602. Available at: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39543920\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/39543920\/<\/a><\/li>\n<li>Marei HE, Khan MUA, Hasan A. Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer&#8217;s disease. Cell Mol Biol Lett. 2023 Nov 30;28(1):98. doi: 10.1186\/s11658-023-00504-2. Available at: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38031028\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/38031028\/<\/a><\/li>\n<li>Leventhal A, Chen G, Negro A, Boehm M. The benefits and risks of stem cell technology. Oral Dis. 2012 Apr;18(3):217-22. doi: 10.1111\/j.1601-0825.2011.01870.x. Available at: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3752464\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3752464\/<\/a><\/li>\n<li>Chen J, Pang A, Zhao Y, Liu L, Ma R, Wei J, Chen X, He Y, Yang D, Zhang R, Zhai W, Ma Q, Jiang E, Han M, Zhou J, Feng S. Primary graft failure following allogeneic hematopoietic stem cell transplantation: risk factors, treatment and outcomes. Hematology. 2022 Dec;27(1):293-299. doi: 10.1080\/16078454.2022.2042064. Available at: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35192779\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/35192779\/<\/a><\/li>\n<li>Derks LLM, van Boxtel R. Stem cell mutations, associated cancer risk, and consequences for regenerative medicine. Cell Stem Cell. 2023 Nov 2;30(11):1421-1433. doi: 10.1016\/j.stem.2023.09.008. Available at: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10624213\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10624213\/<\/a><\/li>\n<li>Mohty B, Mohty M. Long-term complications and side effects after allogeneic hematopoietic stem cell transplantation: an update. Blood Cancer J. 2011 Apr;1(4):e16. doi: 10.1038\/bcj.2011.14 Available at: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22829137\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/22829137\/<\/a><\/li>\n<li>Bhatia S. Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up. Expert Rev Hematol. 2011 Aug;4(4):437-52; quiz 453-4. doi: 10.1586\/ehm.11.39. Available at: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21801135\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/21801135\/<\/a><\/li>\n<li>Mulia GJ, Anna N, Wu JC, Ma HP, Chiang YH, Ou JC, Chen KY. Stem Cell-Based Therapies via Different Administration Route for Stroke: A Meta-analysis of Comparative Studies. Cell Transplant. 2025 Jan-Dec;34:9636897251315121. doi: 10.1177\/09636897251315121. Available at: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39925239\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/39925239\/<\/a><\/li>\n<li>Lo B, Parham L. Ethical issues in stem cell research. Endocr Rev. 2009 May;30(3):204-13. doi: 10.1210\/er.2008-0031. Available at: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC2726839\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC2726839\/<\/a><\/li>\n<li>de Wert G, Mummery C. Human embryonic stem cells: research, ethics and policy. Hum Reprod. 2003 Apr;18(4):672-82. doi: 10.1093\/humrep\/deg143. Available at: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/12660256\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/12660256\/<\/a><\/li>\n<li>Zheng YL. Some Ethical Concerns About Human Induced Pluripotent Stem Cells. Sci Eng Ethics. 2016 Oct;22(5):1277-1284. doi: 10.1007\/s11948-015-9693-6. Available at: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26276162\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/26276162\/<\/a><\/li>\n<li>Sipp D. The unregulated commercialization of stem cell treatments: a global perspective. Front Med. 2011 Dec;5(4):348-55. doi: 10.1007\/s11684-011-0150-x. Available at: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21964637\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/21964637\/<\/a><\/li>\n<li>Riva L, Campanozzi L, Vitali M, Ricci G, Tambone V. Unproven stem cell therapies: is it my right to try? Ann Ist Super Sanita. 2019 Apr-Jun;55(2):179-185. doi: 10.4415\/ANN_19_02_10. Available at: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31264641\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/31264641\/<\/a><\/li>\n<li>Aly RM. Current state of stem cell-based therapies: an overview. Stem Cell Investig. 2020 May 15;7:8. doi: 10.21037\/sci-2020-001. Available at: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7367472\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7367472\/<\/a><\/li>\n<li>Alessio N, Brigida AL, Peluso G, Antonucci N, Galderisi U, Siniscalco D. Stem Cell-Derived Exosomes in Autism Spectrum Disorder. Int J Environ Res Public Health. 2020 Feb 4;17(3):944. doi: 10.3390\/ijerph17030944. Available at: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7037429\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7037429\/<\/a><\/li>\n<li>Jiang W, Xu J. Immune modulation by mesenchymal stem cells. Cell Prolif. 2020 Jan;53(1):e12712. doi: 10.1111\/cpr.12712. Available at: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6985662\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6985662\/<\/a><\/li>\n<li>du Pr\u00e9 BC, Doevendans PA, van Laake LW. Stem cells for cardiac repair: an introduction. J Geriatr Cardiol. 2013 Jun;10(2):186-97. doi: 10.3969\/j.issn.1671-5411.2013.02.003. Available at: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3708059\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3708059\/<\/a><\/li>\n<li>Reddy PH. Current status of stem cell research: An editorial. Biochim Biophys Acta Mol Basis Dis. 2020 Apr 1;1866(4):165635. doi: 10.1016\/j.bbadis.2019.165635. Epub 2019 Dec 17. PMID: 31862303. https:\/\/pubmed.ncbi.nlm.nih.gov\/31862303\/<\/li>\n<li>Hussen BM, Taheri M, Yashooa RK, Abdullah GH, Abdullah SR, Kheder RK, Mustafa SA. Revolutionizing medicine: recent developments and future prospects in stem-cell therapy. Int J Surg. 2024 Dec 1;110(12):8002-8024. doi: 10.1097\/JS9.0000000000002109. Available at: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11634165\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11634165\/<\/a><\/li>\n<li>Patmanathan SN, Gnanasegaran N, Lim MN, Husaini R, Fakiruddin KS, Zakaria Z. CRISPR\/Cas9 in Stem Cell Research: Current Application and Future Perspective. Curr Stem Cell Res Ther. 2018;13(8):632-644. doi: 10.2174\/1574888X13666180613081443. Available at: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29895256\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/29895256\/<\/a><\/li>\n<li>Foltz LP, Clegg DO. Patient-derived induced pluripotent stem cells for modelling genetic retinal dystrophies. Prog Retin Eye Res. 2019 Jan;68:54-66. doi: 10.1016\/j.preteyeres.2018.09.002. Available at: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30217765\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/30217765\/<\/a><\/li>\n<li>Tasnim N, De la Vega L, Anil Kumar S, Abelseth L, Alonzo M, Amereh M, Joddar B, Willerth SM. 3D Bioprinting Stem Cell Derived Tissues. Cell Mol Bioeng. 2018 May 21;11(4):219-240. doi: 10.1007\/s12195-018-0530-2. Available at: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6816617\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6816617\/<\/a><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Terapia cu celule stem \u00een neurologie Terapia cu celule stem \u00een neurologie a\u00a0deschis noi direc\u021bii pentru \u00een\u021belegerea, tratarea \u0219i poten\u021biala vindecare a unei game largi de tulbur\u0103ri neurologice [17]. Bolile neurologice precum Parkinson, Alzheimer, scleroza multipl\u0103, scleroza lateral\u0103 amiotrofic\u0103 \u0219i leziunile m\u0103duvei spin\u0103rii se refer\u0103 la degenerarea progresiv\u0103 \u0219i moartea celulelor neuronale \u0219i de sustinere [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":2014,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jnews-multi-image_gallery":[],"jnews_single_post":{"subtitle":"","format":"standard","override":[{"template":"6","parallax":"1","fullscreen":"1","layout":"no-sidebar","sidebar":"default-sidebar","second_sidebar":"default-sidebar","sticky_sidebar":"1","share_position":"floatbottom","share_float_style":"share-normal","show_share_counter":"1","show_view_counter":"1","show_featured":"1","show_post_meta":"1","show_post_author_image":"1","show_post_date":"1","post_date_format":"default","post_date_format_custom":"Y\/m\/d","show_post_category":"1","show_post_reading_time":"1","post_reading_time_wpm":"300","post_calculate_word_method":"str_word_count","show_zoom_button":"1","zoom_button_out_step":"2","zoom_button_in_step":"3","show_post_tag":"1","show_popup_post":"1","number_popup_post":"3","show_post_related":"1","show_inline_post_related":"0"}],"image_override":[{"single_post_thumbnail_size":"crop-500","single_post_gallery_size":"crop-500"}],"trending_post_position":"meta","trending_post_label":"Trending","sponsored_post_label":"Sponsored by","disable_ad":"0"},"jnews_primary_category":[],"jnews_override_counter":{"view_counter_number":"0","share_counter_number":"0","like_counter_number":"0","dislike_counter_number":"0"},"footnotes":""},"categories":[6],"tags":[],"class_list":["post-2006","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-neurologie"],"_links":{"self":[{"href":"https:\/\/roneuro.ro\/blog\/wp-json\/wp\/v2\/posts\/2006","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/roneuro.ro\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/roneuro.ro\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/roneuro.ro\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/roneuro.ro\/blog\/wp-json\/wp\/v2\/comments?post=2006"}],"version-history":[{"count":7,"href":"https:\/\/roneuro.ro\/blog\/wp-json\/wp\/v2\/posts\/2006\/revisions"}],"predecessor-version":[{"id":2104,"href":"https:\/\/roneuro.ro\/blog\/wp-json\/wp\/v2\/posts\/2006\/revisions\/2104"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/roneuro.ro\/blog\/wp-json\/wp\/v2\/media\/2014"}],"wp:attachment":[{"href":"https:\/\/roneuro.ro\/blog\/wp-json\/wp\/v2\/media?parent=2006"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/roneuro.ro\/blog\/wp-json\/wp\/v2\/categories?post=2006"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/roneuro.ro\/blog\/wp-json\/wp\/v2\/tags?post=2006"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}